Medtronic plc (SA:MDTC34) — Market Cap & Net Worth
Market Cap & Net Worth: Medtronic plc (MDTC34)
Medtronic plc (SA:MDTC34) has a market capitalization of $104.84 Billion (R$534.32 Billion) as of September 16, 2026. Listed on the SA stock exchange, this Brazil-based company holds position #239 globally and #8 in its home market, demonstrating a -6.39% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medtronic plc's stock price R$208.39 by its total outstanding shares 2564028416 (2.56 Billion). Also see total assets of Medtronic plc for a full breakdown of the balance sheet.
Medtronic plc Market Cap History: 2016 to 2026
Medtronic plc's market capitalization history from 2016 to 2026. Data shows growth from $49.34 Billion to $30.37 Billion (6.08% CAGR). Also see cash efficiency ratio of Medtronic plc for how efficiently the company converts equity into cash flow.
Medtronic plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medtronic plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of Medtronic plc for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.84x
Medtronic plc's market cap is 0.84 times its annual revenue
Latest Price to Earnings (P/E) Ratio
6.33x
Medtronic plc's market cap is 6.33 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $97.26 Billion | $30.56 Billion | $4.63 Billion | 3.18x | 21.00x |
| 2020 | $132.48 Billion | $28.91 Billion | $4.79 Billion | 4.58x | 27.66x |
| 2021 | $132.50 Billion | $30.12 Billion | $3.61 Billion | 4.40x | 36.74x |
| 2022 | $96.93 Billion | $31.69 Billion | $5.04 Billion | 3.06x | 19.24x |
| 2023 | $99.02 Billion | $31.23 Billion | $3.76 Billion | 3.17x | 26.35x |
| 2024 | $123.56 Billion | $32.36 Billion | $3.68 Billion | 3.82x | 33.61x |
| 2025 | $133.83 Billion | $33.54 Billion | $4.66 Billion | 3.99x | 28.70x |
| 2026 | $30.37 Billion | $36.36 Billion | $4.80 Billion | 0.84x | 6.33x |
Competitor Companies of MDTC34 by Market Capitalization
Companies near Medtronic plc in the global market cap rankings as of September 16, 2026. Review MDTC34 goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Medtronic plc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #125 globally with a market cap of $177.42 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Medtronic PLC (XETRA:2M6): Ranked #319 globally with a market cap of $83.04 Billion USD ( €71.03 Billion EUR).
- Boston Scientific Corp (NYSE:BSX): Ranked #435 globally with a market cap of $65.21 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #125 | Abbott Laboratories | NYSE:ABT | $177.42 Billion | $102.03 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $93.75 |
| #319 | Medtronic PLC | XETRA:2M6 | $83.04 Billion | €69.20 |
| #435 | Boston Scientific Corp | NYSE:BSX | $65.21 Billion | $43.87 |
Medtronic plc Historical Marketcap From 2016 to 2026
Between 2016 and today, Medtronic plc's market cap moved from $49.34 Billion to $ 30.37 Billion, with a yearly change of 6.08%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | R$30.37 Billion | -77.31% |
| 2025 | R$133.83 Billion | +8.31% |
| 2024 | R$123.56 Billion | +24.79% |
| 2023 | R$99.02 Billion | +2.15% |
| 2022 | R$96.93 Billion | -26.84% |
| 2021 | R$132.50 Billion | +0.01% |
| 2020 | R$132.48 Billion | +36.21% |
| 2019 | R$97.26 Billion | +25.84% |
| 2018 | R$77.28 Billion | +39.67% |
| 2017 | R$55.33 Billion | +12.15% |
| 2016 | R$49.34 Billion | -- |
End of Day Market Cap According to Different Sources
On Apr 24th, 2026 the market cap of Medtronic plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $104.84 Billion USD |
| MoneyControl | $104.84 Billion USD |
| MarketWatch | $104.84 Billion USD |
| marketcap.company | $104.84 Billion USD |
| Reuters | $104.84 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Medtronic plc
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor sy… Read more